Defence Therapeutics Inc (CSE: DTC )
0.7400
-0.0200
(-2.63%)
Official Closing Price
Updated: 9:32 AM EDT, Aug 9, 2024
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
More NewsRead More![]()
Defence Therapeutics Key Platform Patent Accepted Broadly Covering Vaccine Technology
November 07, 2023
Via PressReach
Topics
Intellectual Property
Exposures
Intellectual Property
![]() Via PressReach
Exposures
Product Safety
![]()
Bristol Myers Squibb Enters the Multi-Billion-Dollar Oncology Race
October 17, 2023
Via PressReach
![]()
Bristol Myers Squibb Joins Big Pharma’s Race to Dominate Oncology
October 17, 2023
Via PressReach
![]() ![]()
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
October 10, 2023
Via PressReach
![]()
Big Pharma’s Billion-Dollar Bets on Advanced Cancer Therapies
October 10, 2023
Via PressReach
Exposures
COVID-19
![]() ![]()
Defence Therapeutics Applauds United States President Biden Cancer Moonshot Initiative
September 16, 2022
Via Newsfile
Via Newsfile
Defence Therapeutics Advances in Pre-Clinical Testing of Its Infectious Disease Vaccine Program
May 31, 2021
Via Newsfile
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|